Delivery Order SPE2DB20D3104-SPE2DB22FV8Q2

Award Date 8/5/22
Potential Completion Date 8/8/22
Potential Value $6.5K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $5,822.67 firm fixed-price delivery order is for the supply of MONOVISC 88 MG/4 ML SYRINGE 4ML, a medical product. The contract has an ultimate completion date of November 18, 2024. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $8,230.33 firm fixed-price delivery order is for the medical product MONOVISC 88 MG/4 ML SYRINGE 4ML. The contract has an ultimate completion date of December 17, 2024. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a...
This federal contract award is a delivery order valued at $5,692.33 awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA). The contract is for the supply of MONOVISC 88 MG/4 ML SYRINGE 4ML, a medical product, with a completion date of October 23, 2024. This award is not designated as a set-aside contract. Amerisourcebergen holds a substantial Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999...
This federal contract award, valued at $10,454.83, was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a delivery order for the supply of 4566433840 MONOVISC 88 MG/4 ML SYRINGE 4ML, with a completion date of November 15, 2024. Amerisourcebergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $8,382.31 firm fixed price delivery order is for the supply of MONOVISC 88 MG/4 ML SYRINGE 4ML, a medical product. This award is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that Amerisourcebergen holds with the DLA Troop Support Medical, which provides a comprehensive range of...
This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $4,041.24, is a delivery order for the supply of MONOVISC 88 MG/4 ML SYRINGE 4ML medical products. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026, which...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $7,966.15 Firm Fixed Price delivery order contract is for the supply of MONOVISC 88 MG/4 ML SYRINGE 4ML, a medical product. This delivery order is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) that Amerisourcebergen holds with the DLA Troop Support Medical, which serves as a primary vehicle for...
This federal contract award to Amerisourcebergen Drug Corp is a delivery order valued at $49,197.94 awarded by the Defense Logistics Agency (DLA). The contract is for the delivery of MONOVISC 88 MG/4 ML SYRINGE 4ML, a medical supply item, with a completion date of October 26, 2023. The contract is a firm-fixed-price arrangement and does not have a set-aside designation, indicating open competition. Amerisourcebergen Drug Corp is a major pharmaceutical distributor and healthcare solutions...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $6,009.60 firm fixed-price delivery order is for the supply of MONOVISC 88 MG/4 ML syringes. This award is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA Troop Support Medical, which provides a comprehensive range of pharmaceutical products and medical...
This federal contract award, valued at $7,086.37, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of MONOVISC 88 MG/4 ML SYRINGE 4ML, a pharmaceutical product, with a completion date of January 5, 2024. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through...
  • SPE2DB20D3104
    Indefinite Delivery Contract
  • SPE2DB20D3104-SPE2DB22FV8Q2
    Delivery Order

This federal contract award, valued at $6,538.44, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award is a delivery order for 4,558,011,128 MONOVISC 88 MG/4 ML SYRINGE 4ML, a pharmaceutical product. The contract is a firm fixed-price arrangement with an ultimate completion date of August 8, 2022. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026, which serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. This delivery order is part of that larger IDC contract. The contract has no set-aside designation, indicating open competition.

Generated 2/27/25, 1:27 PM